We accept
Tesamorelin is a potent peptide that often generates confusion regarding its use, safety and legal status. It is essential to understand that, unlike many other peptides in the gray fitness market, Tesamorelin has a legitimate clinical origin and a very specific medical purpose approved by regulatory bodies.
This guide explains the medical and legal reality of this compound.
Tesamorelin is a synthetic analogue of growth hormone releasing factor (GHRH). It works by stimulating the pituitary gland so that it produces and secretes more of its own endogenous growth hormone (HGH).
FDA Approval (EE.UU.)
The Food and Drug Administration of the United States (FDA) approved Tesamorelin under the commercial name Egrifta (and later Egrifta SV) in November 2010.
Specific Medical Indication:
Its ONLY approved indication is for the reduction of excess abdominal fat (visceral lipodystrophy) in adult patients infected with HIV (Human Immunodeficiency Virus) who are receiving antiretroviral therapy.
Therapy against HIV can cause an anomalous redistribution of body fat, accumulating deep and hard visceral fat around the organs in the abdomen, which in the ground is aesthetically problematic, causing severe metabolic and cardiovascular risks. Tesamorelin has been shown in clinical trials to significantly reduce this visceral fat.
Limitations of Approval
The FDA was very clear on its limitations:
It is NOT approved for general weight loss (obesity).
It is NOT approved for cosmetic use or improving sports performance in healthy people.
It has not been shown to reduce the cardiovascular risk associated with lipodystrophy, just by reducing fat itself.
Although Tesamorelin is considered generally safe when used according to indications and under supervision, it is a potent medicine that alters key hormonal effects and alleviates well-documented risks.
Common and Light Secondary Effects
In clinical trials, the most frequent adverse reactions included:
Reactions at the injection site: Redness, stinging, pain, irritation or small bumps in the area where the subcutaneous injection is applied (generally the abdomen).
Musculoskeletal pain: Arthralgia (joint pain), myalgia (muscle pain) and stiffness in the extremities.
Mild fluid retention: Peripheral edema (swelling in hands or feet).
Serious Risks and Important Safety Considerations
This is the most significant metabolic risk. The increase in growth hormone can induce insulin resistance.
Treatment with Tesamorelin can raise blood glucose levels and increase hemoglobin A1c (HbA1c).
It can worsen existing diabetes or precipitate the appearance of type 2 diabetes in predisposed patients.
This is why supervision is critical: Regular monitoring of blood glucose and HbA1c before and during treatment is required.
Tesamorelin works by raising the levels of Growth Factor Similar to Type 1 Insulin (IGF-1). Although IGF-1 is necessary for the benefits of the drug, chronically very high levels are theoretically associated with a greater risk of developing the progression of certain malignant tumors.
Absolute Contraindication: Tesamorelin should NOT be used in patients with active cancer, whether recently diagnosed or recurrent. Any pre-existing malignant tumor must be inactive and treatment completed before considering Tesamorelin.
Doctors must monitor IGF-1 levels to ensure that they do not excessively exceed the normal range for the patient's age and sex.
Cases of systemic allergic reactions (hypersensitivity) have been reported, which may include severe skin rashes or hives. If this occurs, the treatment must be suspended immediately.
Although less common with secretagogues than with direct HGH, excess growth hormone can cause significant fluid retention that compresses nerves, leading to symptoms such as carpal tunnel syndrome.
Given the safety profile described, the use of Tesamorelin without strict medical supervision is reckless and dangerous.
In Spain and most developed countries, access to legitimate pharmaceutical-grade Tesamorelin (such as Egrifta) requires a medical prescription.
What does adequate medical supervision imply?
A qualified doctor (generally an endocrinologist or specialist in infectious diseases in the context of HIV) on the ground writes a prescription, which manages the entire process:
Complete medical history to rule out past active cancer.
Assessment of diabetic or prediabetic status.
Complete baseline blood analysis, including glucose levels, HbA1c, lipid profile and IGF-1 levels.
Glucemic Control: Periodic glucose and HbA1c tests to detect insulin resistance or diabetes development early.
IGF-1 Monitoring: Ensure that levels do not rise to dangerous levels.
Monitoring for Adverse Effects: Evaluate any persistent joint pain, signs of carpal tunnel or severe skin reactions.
Efficacy Review: The doctor will evaluate whether the drug is working (measuring the waist circumference or using scans). If there is no clear response after a certain period, the treatment must be suspended so as not to expose the patient to unnecessary risks.
Summary of the “Off-Label” Situation”
It is well known that Tesamorelin is used throughout the HIV clinical circuit by bodybuilders and fitness enthusiasts to lose abdominal fat.
It is crucial to understand that this use is “off-label” (for indication):
It is not approved by the FDA or European agencies.
This often implies the use of “research grade” peptides purchased online, whose purity, sterility and real dosage are unknown, adding a massive layer of additional risk.
When carried out without a doctor who controls glucose and IGF-1, the user is “flying a blind eye” in the face of potentially serious metabolic and oncological risks.
Conclusion: Tesamorelin is a potent medicine with very narrow and specific approval. Its safety profile is manageable only within a structured clinical framework with constant medical monitoring. Its recreational or self-administered use carries significant health risks that should not be underestimated.
SERMORELIN PEPTIDE.
Recommended for improving your health, your well-being and your recovery.
How it works:
Stimulates the pituitary gland to release natural GH, activating the body's physiological production.
For whom is it indicated:
Peopleas con sueño lighto.
Patients with fatigue and low energy.
Men and women older than 30 years.
People looking for gentle anti-aging.
People who want to improve their skin and collagen.
What a improvement:
Deep dream.
Muscle recovery.
Slight increase in muscle mass.
Firmness of the skin.
Energy and vitality.
Sermorelin → smooth and sueño natural GH.
Safe and effective under the supervision of a specialist doctor.
Approved by the FDA.
Tesamorelin peptide.
Powerful for visceral fat and metabolism.
How it works:
Stimulates GH and IGF-1 with greater intensity, improving body composition and reducing persistent abdominal fat.
For whom is it indicated:
Persons with persistent abdominal fat.
Slow metabolism.
From the age of 30-35.
Those looking for performance and aesthetics.
They may find it difficult to gain muscle mass.
What a improvement:
Reduction of visceral fat.
Increase in lean mass.
Deep dream.
Muscle recovery.
Energy and vitality.
Fast metabolism.
Tesamorelin: Visceral fat and metabolism.
Safe and effective under the supervision of a qualified doctor.
Approved by the FDA.
Elamipretide SS-31 peptide.
Mitochondrial peptide: energy, concentration and longevity.
How it works:
It acts directly on the mitochondria, restoring energy efficiency and reducing cellular inflammation.
For whom is it indicated:
Constant fatigue.
Low vitality.
Seniors over 35 years old.
Overworked professionals and sportspeople.
Quienes buscan longevidad.
What a improvement:
ATP energy.
Concentration and mental clarity.
Muscle recovery.
Cellular protection.
Mood and well-being.
Longevity.
SS-31 Mitochondrial energy and deep anti-aging.
Safe and effective if used under the supervision of a qualified doctor.
Approved by the FDA.
Doctor G Medical Excellence: Health, Bienestar and Longevidad
4243 W Hillsboro blvd Coconut Creek, 33073, FL
Phone: +1 (954) 638-1515
| Monday | 09:00 - 17:00 |
| Tuesday | 09:00 - 17:00 |
| Wednesday | 09:00 - 17:00 |
| Thursday | 09:00 - 17:00 |
| Friday | 09:00 - 17:00 |
| Saturday | 09:00 - 17:00 |
| Sunday | Closed |